U.S. Markets closed

Medivolve Inc. (COPRF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0299+0.0014 (+4.91%)
At close: 09:43AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0285
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0237 - 0.0299
52 Week Range0.0140 - 0.2000
Avg. Volume160,827
Market Cap11.7M
Beta (5Y Monthly)2.96
PE Ratio (TTM)N/A
EPS (TTM)-0.1440
Earnings DateNov 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Medivolve Provides Update on its Mobile Clinic Network

    TORONTO, July 26, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare technology and services company, is pleased to provide an update on the Company’s business and operations. The Company’s primary business activities are conducted through its wholly owned subsidiary, Collection Sites LLC, which has over 190 employees and has built a network of 22 mobile COVID-19 testing centers across the United States, including in the states of C

  • GlobeNewswire

    Medivolve Announces Results of Annual and Special Shareholder Meeting

    TORONTO, June 16, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: COPRF; FRA:4NC), reports, in accordance with the policies of the NEO Exchange, that the nominees listed in the Management Information Circular dated May 16, 2022 for the 2022 Annual and Special Meeting of Shareholders of the Company (the “Meeting”) were elected as directors of the Company. 21.82% of all of the issued and outstanding shares of the Company were represented at the Meeting. Det

  • GlobeNewswire

    Medivolve Announces Q1 2022 Financial Results

    Cash on hand was $8,327,812 as at March 31, 2022, up 7,309% compared to $112,397 as at December 31, 2021.Cash provided by operating activities was $8,211,415 in the three months ending March 31, 2022, compared to cash used by operating activities of $4,382,478 in the prior three months ending March 31, 2021.Revenue was $16,693,947 in the three months ending March 31, 2022, up 48%, compared to $11,248,001 over the prior three months ending March 31, 2021.Gross profit was $6,409,277 in the three m